Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 3Completed 3Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Breast 1

Conditions

Prostatic Neoplasms 2Sarcopenia 1Muscle Weakness 1Motor Activity 1Breast Neoplasms 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Creatine × Clear all
NCT06112990 2026-06-03

CREATINE-52

University of Utah

Phase 3 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT07463092 2026-04-08

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

University of Sao Paulo

Phase NA Recruiting
34 enrolled
Genitourinary

Prostatic Neoplasms, Sarcopenia

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡